Editorial introductions

Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. Section Editors Hal BroxmeyerFigure 1Dr Hal Broxmeyer is Distinguished Professor, Mary Margaret Walther Professor Emeritus, Professor of Microbiology and Immunology, Co-Leader Program on Hematopoiesis, Heme Malignancies and Immunology, Indiana University Simon Cancer Center, former Scientific Director, Walther Oncology Center, and former Chairman, Department of Microbiology and Immunology at the Indiana University School of Medicine, Indianapolis, USA. He received a BS degree, Brooklyn College, City University of New York, USA in 1966, an MS degree from Long Island University, Brooklyn Center in 1969 and a PhD from New York University in 1973. He did post-doctoral training in 1973–1975 at Kingston General Hospital, Queens University Kingston, Ontario, Canada. From 1975–1983 he worked at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City rising from the ranks of associate researcher to that of associate member. He was also assistant professor of Biology, Sloan Kettering Division of Cornell University Graduate School of Medical Sciences, New York, before being recruited to the Indiana University School of Medicine in 1983 as an associate professor of medicine. To date, he has published 682 scientific papers (480 refereed papers and 202 reviews/book chapters). Broxmeyer's laboratory studies mechanisms regulating hematopoietic stem and progenitor cells, embryonic stem cells and induced pluripotent stem cells proliferation, self-renewal, survival, differentiation and migration (homing/mobilization); and immune cell activities. He was involved in establishing the field of cord blood transplantation. Dr Broxmeyer's Awards include: New York University Founders Day Award (1973); Mellor Award (2nd prize 1976; 1st prize 1977) and Boyer Award (1983) from MSKCC; Special Fellow (1976–1978) and Scholar Award (1978–1983) from the Leukemia Lymphoma Society; Merit Award, National Cancer Institute (1987–1995); Variety Club Award (1992 and 1993), Indiana; Gold Medal of City of Paris (1993); World of Difference Award, Indiana Health Industry Forum (1997); Who's Who in Health Care, Indianapolis Business Journal (IBJ) (2002); Health Care Heroes Award, IBJ (2002); Karl Landsteiner Award, American Association of Blood Banks (2002); Prestigious External Award Recognition, IUPUI (2003); Distinguished Alumni Award, Long Island University (2005); Joseph T. Taylor Excellence in Diversity Award, Indiana University (2006); Dirk van Bekkum Award, Autologous Blood and Bone Marrow Society (2006); E. Donnall Thomas Prize and Lecture, American Society of Hematology (2007); Glenn W. Irwin Jr. M.D., Distinguished Faculty Award, Indiana University School of Medicine Alumni Association (2008); and State of Indiana General Assembly House Resolution No. 46 (2008); Mission Advancement Award, Leukemia Lymphoma Society (2008); Cord Blood Pioneering Award, Int. Cord Blood Symposium (2008); Till and McCullough Award, Canadian Bone Marrow Transplant Group (2010); and Donald Metcalf Award, Int. Soc. Expt. Hematol. (2011). Dr Broxmeyer is past President of the American Society of Hematology (ASH; 2010) and Chairman Emeritus, Board of Directors, National Disease Research Interchange, Philadelphia, PA. Nancy BerlinerFigure 2Dr Berliner is Chief of Hematology at the Brigham and Women's Hospital, Boston, MA, USA. She received her medical degree from Yale Medical School. She then obtained training as a Resident in Internal Medicine, Internal Medicine Chief Resident, and Hematology Fellow at the Brigham and Women's Hospital. She was on the faculty of the Yale University School of Medicine for over 20 years, where she rose through the ranks to Professor of Internal Medicine and Genetics. She has broad clinical interests in both classical hematology and hematologic malignancies. Her research is focused on the regulation of neutrophil-specific gene expression and its disruption in myelodysplasia and acute leukemia. She received the Stohlman Prize from the Leukemia/Lymphoma Society of America. She has served on the Editorial Boards of Blood, the European Journal of Hematology, and the American Journal of Hematology, and Hematology/Oncology Clinics of North America. She is a member of the American Society for Clinical Investigation, the Association of American Physicians, and the Interurban Clinical Club, and is a fellow of the American Association for the Advancement of Science. She was President of the American Society of Hematology in 2009 and was elected to the Institute of Medicine in 2010.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.